NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Immuron Limited (AU: IMC)

 
IMC Technical Analysis
4
As on 31st Oct 2025 IMC STOCK Price closed @ 0.08 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.09 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IMCSTOCK Price

Open 0.09 Change Price %
High 0.09 1 Day -0.01 -11.11
Low 0.08 1 Week 0.00 0.00
Close 0.08 1 Month 0.00 0.00
Volume 396990 1 Year -0.01 -11.11
52 Week High 0.11 | 52 Week Low 0.06
 
AU Australia Most Active Stocks
MRD 0.03 %
RML 0.10 %
ARU 0.28 0.00%
NTU 0.04 0.00%
ATH 0.01 0.00%
PLS 3.30 0.00%
RMS 3.32 1.22%
EQR 0.04 -20.00%
EUR 0.26 30.00%
VR1 0.04 %
 
AU Australia Top Gainers Stocks
SRJ 0.02 100.00%
SRJ 0.02 100.00%
SRJ 0.02 100.00%
SRJ 0.02 100.00%
APV 0.02 100.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
SCI 0.03 50.00%
 
AU Australia Top Losers Stocks
THR 0.01 -50.00%
THR 0.01 -50.00%
THR 0.01 -50.00%
RIM 0.01 -50.00%
CPO 0.01 -50.00%
8IH 0.03 -40.00%
TAS 0.02 -33.33%
TAS 0.02 -33.33%
SOP 0.02 -33.33%
SOP 0.02 -33.33%
 
 
IMC
Daily Charts
IMC
Intraday Charts
Whats New @
Bazaartrend
IMC
Free Analysis
 
IMC Important Levels Intraday
RESISTANCE0.10
RESISTANCE0.09
RESISTANCE0.09
RESISTANCE0.09
SUPPORT0.07
SUPPORT0.07
SUPPORT0.07
SUPPORT0.06
 
IMC Forecast November 2025
4th UP Forecast0.12
3rd UP Forecast0.11
2nd UP Forecast0.1
1st UP Forecast0.09
1st DOWN Forecast0.07
2nd DOWN Forecast0.06
3rd DOWN Forecast0.05
4th DOWN Forecast0.04
 
IMC Weekly Forecast
4th UP Forecast0.10
3rd UP Forecast0.09
2nd UP Forecast0.09
1st UP Forecast0.09
1st DOWN Forecast0.07
2nd DOWN Forecast0.07
3rd DOWN Forecast0.07
4th DOWN Forecast0.06
 
IMC Forecast2025
4th UP Forecast0.2
3rd UP Forecast0.16
2nd UP Forecast0.14
1st UP Forecast0.11
1st DOWN Forecast0.05
2nd DOWN Forecast0.02
3rd DOWN Forecast0
4th DOWN Forecast-0.04
 
 
IMC Other Details
Segment EQ
Market Capital 29542110.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IMC Address
IMC
 
IMC Latest News
 
Your Comments and Response on Immuron Limited
 
IMC Business Profile
Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for dietary supplement for digestive tract protection; and Protectyn, an immune supplement to maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III clinical trials to reduce the risk of contracting travelers' diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in clinical development stage focuses on treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and ETEC infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is based in Carlton, Australia. Address: 25-37 Chapman Street, Carlton, VIC, Australia, 3130
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service